ITEMS OF INTEREST TO THE IMAGING RESEARCH COMMUNITY:
CIP Web Site: http://www.cancer.gov/bip
- Re-issue of EXPLORATORY/DEVELOPMENTAL GRANTS FOR DIAGNOSTIC CANCER IMAGING (PA-01-030)
The Cancer Imaging Program (CIP), of the Division of Cancer Treatment and Diagnosis (DCTD) solicits exploratory/developmental (R21) grants that articulate highly innovative research concepts in diagnostic cancer imaging. Within each area of importance in imaging, there exists a need for innovative and creative approaches leading to new avenues of research. One way to encourage research into high risk/high impact areas is to provide investigators with the initial resources required to accomplish feasibility and pilot testing of innovative ideas.
- 2001 NIH REGIONAL SEMINARS ON PROGRAM FUNDING AND GRANTS ADMINISTRATION MARCH 15-16 AND JUNE 7-8, 2001 (NOT-OD-01-010)
March 15 and 16: Houston, Texas, co-hosted by the University of Texas MD Anderson Cancer Center, University of Texas Houston Health Science Center and University of Texas Galveston Medical Branch. June 7 and 8, Portland, Oregon, hosted by Oregon Health Sciences University.
- SPONDYLOARTHROPATHIES: NEW APPROACHES TO PATHOGENESIS (AR-00-008) (NIAMS, NEI)
Letter of Intent Receipt Date: January 2, 2001; Application Receipt Date: March 13, 2001
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and the National Eye Institute (NEI) invite applications for research on the pathogenesis of ankylosing spondylitis (AS) and related diseases and on the development of innovative therapeutic approaches.
- NEUROCOGNITIVE, NEUROIMAGING, AND NEUROPSYCHIATRIC CORRELATES OF HIV INFECTION (RFA-MH-01-007) (NIMH, NIDA, NICHD)
Letter of Intent Receipt Date: February 13, 2001; Application Receipt Date: March 20, 2001
The National Institute of Mental Health (NIMH), the National Institute on Drug Abuse (NIDA) and the National Institute of Child Health and Human Development (NICHD) invite research grant applications through this Request for Applications (RFA) to support research focused on the neuropsychological, neurobehavioral, neuroimaging and neuropsychiatric correlates of human immunodeficiency virus/central nervous system (HIV/CNS) disease.
- NCRR SHARED INSTRUMENTATION GRANT (PAR-01-034) (NCRR)
Application Receipt Date: March 23, 2001
The objective of the program is to make available to institutions expensive research instruments that can only be justified on a shared-use basis and for which meritorious research projects are described.
- New NCI and NIH Policy on R13 funding
There has been a recent NIH policy change, which allows multi-year applications for recurring conferences. Program staff strongly encourage organizations holding annual or biennial series of conferences to submit five-year applications to reduce time and effort by the applicants and by NCI staff. Multi-year applications should include detailed plans for the current conferences and also describe the processes that will be used to set up future conferences. R13 applicants should submit applications at least six months in advance of the conference to allow for orderly review and award. One problem that should be noted is that Awards cannot "skip years" for biennial conferences; however, to work around this issue, applicants might request a small amount for continued secretarial support or for publication of the meeting proceedings in the other years.
The guidelines for Support of Scientific Meetings by NIH can be found at: http://grants.nih.gov/grants/guide/notice-files/not98-151.html
- MINIMALLY INVASIVE SURGICAL THERAPIES TREATMENT CONSORTIUM FOR BENIGN PROSTATIC HYPERPLASIA (NIDDK) (DK-01-024)
Applicant Information Forum Date: January 12, 2001
Letter of Intent Receipt Date: February 23, 2001
Application Receipt Date: March 20, 2001
The Division of Kidney, Urologic, and Hematologic Diseases (DKUHD) of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) has a substantial and longstanding interest in evaluating the effectiveness of treatment strategies for the symptoms of benign prostatic hyperplasia (BPH).
- BIOENGINEERING RESEARCH PARTNERSHIPS (PA-01-024)
Letter of Intent Receipt Dates: January 16, 2000 and July 13, 2001
Application Receipt Dates: February 16, 2001 and August 14, 2001
Participating Institutes and Centers (ICs) of the National Institutes of Health (NIH) invite applications for R01 awards to support Bioengineering Research Partnerships (BRPs) for basic multidisciplinary research addressing important biological or medical research problems. A BRP is a multidisciplinary research team applying an integrative, systems approach to develop knowledge and/or methods to prevent, detect, diagnose, or treat disease or to understand health and behavior. Consult program before making application.
- FINDINGS OF SCIENTIFIC MISCONDUCT (OD-01-009)
Specifically, the investigator falsified the status of manuscripts in grant applications by listing them as "accepted" or "in press" when the papers had either not been subsequently published or had been rejected. The repetition of these actions over several years indicated a pattern of knowingly misrepresenting the research record.
Other Government Agencies
- NSF Biomedical Engineering Program and Research to Aid Persons with Disabilities Program (BME/RAPD) (NSF 01-12)
DEADLINE: October 12, 2001
Current areas of particular interest in BME/RAPD are biomedical photonics; novel tissue characterization schemes; new cellular and tissue engineering concepts; the innovative integration of multi-disciplinary technologies for new imaging and biosensing systems, etc. Additional information about BME/RAPD is found at http://www.eng.nsf.gov/bes/.
- Major Research Instrumentation (MRI) Program (NSF 01-7)
DEADLINE: February 7, 2001
The MRI Program assists in the acquisition or development of major research instrumentation by U.S. institutions that is, in general, too costly for support through other NSF programs. The maintenance and technical support associated with these instruments is also supported. Proposals may be for a single instrument, a large system of instruments, or multiple instruments that share a common or specific research focus.
- Biophotonics Partnership Initiative II (NSF 01-30)
Deadline Date: March 12, 2001
The Division of BioEngineering and Environmental Systems of the National Science Foundation (NSF) announces a Biophotonics Partnership initiative seeking high risk/high return, multidisciplinary studies of novel concepts in biophotonics. Incremental advances of existing technologies will not be considered. NIH and DARPA will participate in the reviews and identify proposals of mutual interest and may provide co-funding for programs of high quality that meet their programatic and relevancy requirements.
- AMERICAN ASSOCIATION OF PHYSICISTS IN MEDICINE
Deadline: February 1, 2001
Fellowships and Residencies Announced - Support of Clinical Residency in Imaging Support for Clinical Residencies in Radiation Oncology Fellowship for Graduate Study in Medical Physics
- Komen Foundation Grant Programs
Deadline: March 15, 2001
For eighteen years, the Susan G. Komen Breast Cancer Foundation has provided funding for basic, clinical and translational breast cancer research and for innovative projects in the areas of breast health education and breast cancer screening and treatment. In addition, the Foundation awards three-year postdoctoral fellowships.
The Cancer Imaging Program at NCI has created this e-mail distribution list to notify interested people about funding opportunities and other issues related to imaging research. Its primary purpose is to call your attention to important, relevant information on NIH Web pages, or in the NIH Guide. Occasionally it may be used to clarify areas of confusion, or disseminate answers to frequently asked questions.
If you wish to remain on the list, no action is necessary. If you wish to be added to the list (or removed from it), please contact Ms. Johnnie Smith by return e-mail (firstname.lastname@example.org).
Cancer Imaging Program
Division of Cancer Treatment and Diagnosis, NCI
EPN, Room 6000 - MSC-7412
6130 Executive Boulevard
Bethesda, MD 20892-7440
Tel: 301 496 9531
Fax: 301 480 3507